NIH Reporter #5R01CA273123-05

Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies

NIH grant awarded by the National Cancer Institute to study MYD88L265P mutation and co-occurring mutations in mature B-cell malignancies, aiming to develop preclinical models and test therapies.

Description

This NIH grant supports research on the molecular mechanisms of MYD88L265P mutation and associated genetic alterations in B-cell lymphomas, with the goal of developing preclinical models and testing therapies.

View original record